Jacob Cain

Jacob Cain has experience working as an Associate Director and Scientific Program Leader at the Center for Breakthrough Medicines since September 2022. Prior to that, they worked at Amicus Therapeutics as a Principal Investigator in AAV Potency Assay Development from January 2020 to September 2022.

Jacob Cain earned a Ph.D. degree in Developmental Biology from the University of North Dakota. The duration of their education is not specified.